Latebreakers: FDA OK's OTC Zyrtec

Article

FDA approves allergy treatment Zyrtec (cetirizine HCl) for over-the-counter use

McNeil Consumer Healthcare, a division of McNeil-PPC, has received approval for the allergy treatment Zyrtec (cetirizine HCl) to be used without a prescription for adults and children. Zyrtec relieves symptoms caused by perennial and seasonal allergic rhinitis, commonly referred to as indoor and outdoor upper respiratory allergies. Zyrtec also relieves itching due to hives. The approval comes one week after the FDA granted the company approval to market Zyrtec-D 12 Hour (cetirizine HCl 5 mg/pseudo ephedrine HCl 120 mg), which combines Zyrtec with a decongestant. Zyrtec-D and Zyrtec will be available OTC in late January 2008 in their original prescription strength. With Zyrtec's patent expiring this month, generic Rx versions are also expected to make their debut.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series
Image Credit: jokekung - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.